Virtually everyone in the poultry industry is aware of coccidiosis — a disease caused by protozoan parasites, Eimeria, that develop within the intestine of most domestic and wild animals and birds. The condition is more elusive in turkeys, however.
Coccidiosis vaccination is a critical tool to mitigate economic losses for broiler producers. However, dry litter conditions and low placement densities can complicate successful vaccine replication and subsequent immunizing exposure.
USDA’s Center for Veterinary Biologics has granted Huvepharma a conditional license for the manufacturing and sale of a new turkey coccidiosis vaccine.
The parasitic disease coccidiosis remains one of the most economically significant diseases for turkeys. In 2023, coccidiosis ranked 10th in a US turkey industry survey of 38 health issues. Unfortunately, it often goes unnoticed.
